Lifecore Biomedical, Inc.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5147661046
USD
7.77
0.05 (0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
May'24
May'23
May'22
May'21
May'20
May'19
No of Months
12
12
12
12
12
12
Operating Income
128.00
103.00
111.00
171.00
590.00
557.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
128.00
103.00
111.00
171.00
590.00
557.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
18.00
17.00
15.00
10.00
9.00
5.00
General and Administration Expenses
40.00
38.00
34.00
37.00
70.00
62.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
135.00
122.00
114.00
166.00
596.00
550.00
Operating Profit (PBDIT) excl Other Income
-7.00
-19.00
-3.00
5.00
-6.00
7.00
Other Income
-3.00
1.00
6.00
0.00
-3.00
1.00
Operating Profit (PBDIT)
-2.00
-8.00
10.00
14.00
8.00
23.00
Interest
18.00
17.00
15.00
10.00
9.00
5.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
8.00
10.00
7.00
8.00
18.00
14.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
9.00
-63.00
-20.00
-11.00
-51.00
3.00
Provision for Tax
0.00
0.00
-5.00
-1.00
-13.00
1.00
Profit After Tax
9.00
-64.00
-15.00
-9.00
-38.00
2.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.33
-3.32
-3.97
-1.12
-1.31
0.01
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended May 2024 is 24.20% vs -7.19% in May 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended May 2024 is 63.55% vs -474.59% in May 2023

stock-summary

Interest

YoY Growth in year ended May 2024 is 2.50% vs 13.49% in May 2023

stock-summary

Profit After Tax

YoY Growth in year ended May 2024 is 114.53% vs -315.07% in May 2023

Compare Profit and Loss Results of Lifecore Biomedical, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
128.00
124.00
4.00
3.23%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
128.00
124.00
4.00
3.23%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
18.00
3.00
15.00
500.00%
General and Administration Expenses
40.00
72.00
-32.00
-44.44%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
135.00
141.00
-6.00
-4.26%
Operating Profit (PBDIT) excl Other Income
-7.00
-16.00
9.00
56.25%
Other Income
-3.00
5.00
-8.00
-160.00%
Operating Profit (PBDIT)
-2.00
14.00
-16.00
-114.29%
Interest
18.00
3.00
15.00
500.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
8.00
25.00
-17.00
-68.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
9.00
-21.00
30.00
142.86%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
9.00
-21.00
30.00
142.86%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.3277
-0.2265
0.55
244.68%
Profit And Loss - Net Sales
Net Sales 128.26 Million
in May 2024

Figures in Million
stock-summary

YoY Growth in year ended May 2024 is 24.20% vs -7.19% in May 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -7.19 Million
in May 2024

Figures in Million
stock-summary

YoY Growth in year ended May 2024 is 63.55% vs -474.59% in May 2023

Profit And Loss - Interest
Interest 18.09 Million
in May 2024

Figures in Million
stock-summary

YoY Growth in year ended May 2024 is 2.50% vs 13.49% in May 2023

Profit And Loss - Profit After Tax
Profit After Tax 9.33 Million
in May 2024

Figures in Million
stock-summary

YoY Growth in year ended May 2024 is 114.53% vs -315.07% in May 2023